Is this a race between big pharma and investment firms...who's has the deep pockets to enable continued financing for research...big pharma is certainly motivated...but so are many others...so it can be somewhat of a gamble as well...is FDA approval in the stars...something that has to be though about in the process...and between now and then, there's a lot that can happen...so what is the future for many of the biotech companies...good question...BD
Pick the names of any number of Massachusetts biotechnology companies. Industry observers say many could be likely targets for acquisition in the coming months.
In the wake of news that Cambridge startup Sirtris Pharmaceuticals Inc. (Nasdaq: SIRT) and biotech stalwart Millennium Pharmaceuticals Inc. (Nasdaq: MLNM) would be acquired by far larger international biotechs, experts see many more Bay State biotechnology companies as ripe for the plucking, from small startups to larger established companies with products on the market.
He said smaller biotechs are increasingly prepared to sell themselves to owners with deep pockets because "these (smaller) companies are going to require a lot of capital to ultimately bring a product to market."